FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely pulmonology, and may be used for prevention of cold bronchospasm in the patients suffering the mixed pathology including bronchial asthma, chronic obstructive pulmonary disease and cold hyperresponsiveness. That is ensured by the single introduction of antasthmatics of 12-24 h action 30 minutes before walking in the open air at Arnoldi temperature (-20C)-(-50C). As such preparations, Foradil-combi is introduced in the form of inh...

The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.

Disclosed is an effervescent tablet comprising budesonide and docusate which is as an oral mouth rinsing solution.

Combination of R,R-glycopyrrolate, formoterol and a glucocorticoid selected from budesonide and mometasone or their physiologically acceptable salts is disclosed, wherein said combination is suitable for the treatment of inflammatory diseases selected form the group comprising respiratory diseases selected from asthma or COPD, rheumatism or auto-immune diseases selected from rheumatoid arthritis, glomerulonephritis, multiple sclerosis, Crohn's disease, ulcerative colitis, systemic lupus erythema...

The invention relates to sterile filtered nanoparticulate compositions of beclomethasone and/or budesonide having a surface stabilizer tyloxapol and optionally one or more secondary surface stabilizers absorbed onto the surfaces thereof. The nanoparticulate compositions have an optimal effective average particle size of less than about 150 nm.

Pharmaceutical composition for inhalation containing as active ingredient effective amounts of salmeterol or a physiologically salt of salmeterol or a solvate thereof and budesonide or a therapeutically salt of budesonide or a solvate thereof wherein the molecular ratio of salmeterol component to budesonide component is in the range 1:2 to 1:50 together with a pharmaceutically acceptable carrier.